Matches in SemOpenAlex for { <https://semopenalex.org/work/W2001629499> ?p ?o ?g. }
Showing items 1 to 85 of
85
with 100 items per page.
- W2001629499 endingPage "224" @default.
- W2001629499 startingPage "214" @default.
- W2001629499 abstract "Renin angiotensin system parameters and blood pressure (B.P.) were followed monthly in patients with essential hypertension on metolazone, 5 mg daily for three months and with added propranolol, 40 to 160 mg, for the subsequent three months. On metolazone alone at three months, sitting B.P. declined from 166/108 +/- 14/11 mm Hg to 145/98 +/- 14/9 mm Hg (P less than 0.005). Plasma renin activity (PRA) increased from 3.9 +/- ng/ml/hr to 10.4 +/- 8.6 ng/ml/hr (P less than 0.005); plasma angiotensinogen did not change. Venous blood angiotensin I and II levels (pg/ml) rose initially but returned toward control values. A significant decline in plasma renin substrate reactivity (PRSr) in index occurred. Propranolol addition caused further lowering of only systolic B.P. and predominantly in the standing position, more marked at one month (40 mg) than at three months (160 mg). No significant further changes were observed in any of the measured parameters of renin angiotensin system, except for a rise in PRSr index concomitant with B.P. elevation at three months. Metolazone-induced changes in B.P. showed significant correlations at three months with changes in PRSr index. It is concluded that during chronic metolazone administration, the overall activity of the renin angiotensin system was diminished or unchanged. Propranolol did not inhibit metolazone stimulated PRA but did cause further decline in B.P. in the first two months, unrelated to renin angiotensin system." @default.
- W2001629499 created "2016-06-24" @default.
- W2001629499 creator A5006549067 @default.
- W2001629499 creator A5023404144 @default.
- W2001629499 creator A5031126502 @default.
- W2001629499 creator A5031534766 @default.
- W2001629499 creator A5078824728 @default.
- W2001629499 creator A5080835143 @default.
- W2001629499 date "1977-04-01" @default.
- W2001629499 modified "2023-09-27" @default.
- W2001629499 title "Antihypertensive and Renin Angiotensin Effects Of Metolazone With and Without Propranolol" @default.
- W2001629499 cites W1972646254 @default.
- W2001629499 cites W1975958223 @default.
- W2001629499 cites W1981030543 @default.
- W2001629499 cites W1997388963 @default.
- W2001629499 cites W2008209156 @default.
- W2001629499 cites W2014950781 @default.
- W2001629499 cites W2022861519 @default.
- W2001629499 cites W2040680773 @default.
- W2001629499 cites W2081409739 @default.
- W2001629499 cites W2087585964 @default.
- W2001629499 cites W2095310758 @default.
- W2001629499 cites W2136814822 @default.
- W2001629499 cites W2341221170 @default.
- W2001629499 cites W2341792150 @default.
- W2001629499 cites W2411870008 @default.
- W2001629499 cites W2463144153 @default.
- W2001629499 cites W2472473265 @default.
- W2001629499 doi "https://doi.org/10.1177/009127007701700405" @default.
- W2001629499 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/849995" @default.
- W2001629499 hasPublicationYear "1977" @default.
- W2001629499 type Work @default.
- W2001629499 sameAs 2001629499 @default.
- W2001629499 citedByCount "5" @default.
- W2001629499 crossrefType "journal-article" @default.
- W2001629499 hasAuthorship W2001629499A5006549067 @default.
- W2001629499 hasAuthorship W2001629499A5023404144 @default.
- W2001629499 hasAuthorship W2001629499A5031126502 @default.
- W2001629499 hasAuthorship W2001629499A5031534766 @default.
- W2001629499 hasAuthorship W2001629499A5078824728 @default.
- W2001629499 hasAuthorship W2001629499A5080835143 @default.
- W2001629499 hasConcept C126322002 @default.
- W2001629499 hasConcept C134018914 @default.
- W2001629499 hasConcept C138976137 @default.
- W2001629499 hasConcept C185592680 @default.
- W2001629499 hasConcept C198710026 @default.
- W2001629499 hasConcept C27016395 @default.
- W2001629499 hasConcept C2778151854 @default.
- W2001629499 hasConcept C2779384505 @default.
- W2001629499 hasConcept C2908929049 @default.
- W2001629499 hasConcept C71924100 @default.
- W2001629499 hasConcept C84393581 @default.
- W2001629499 hasConceptScore W2001629499C126322002 @default.
- W2001629499 hasConceptScore W2001629499C134018914 @default.
- W2001629499 hasConceptScore W2001629499C138976137 @default.
- W2001629499 hasConceptScore W2001629499C185592680 @default.
- W2001629499 hasConceptScore W2001629499C198710026 @default.
- W2001629499 hasConceptScore W2001629499C27016395 @default.
- W2001629499 hasConceptScore W2001629499C2778151854 @default.
- W2001629499 hasConceptScore W2001629499C2779384505 @default.
- W2001629499 hasConceptScore W2001629499C2908929049 @default.
- W2001629499 hasConceptScore W2001629499C71924100 @default.
- W2001629499 hasConceptScore W2001629499C84393581 @default.
- W2001629499 hasIssue "4" @default.
- W2001629499 hasLocation W20016294991 @default.
- W2001629499 hasLocation W20016294992 @default.
- W2001629499 hasOpenAccess W2001629499 @default.
- W2001629499 hasPrimaryLocation W20016294991 @default.
- W2001629499 hasRelatedWork W1992835977 @default.
- W2001629499 hasRelatedWork W2016647631 @default.
- W2001629499 hasRelatedWork W2059897048 @default.
- W2001629499 hasRelatedWork W2077998387 @default.
- W2001629499 hasRelatedWork W2126797993 @default.
- W2001629499 hasRelatedWork W2132612653 @default.
- W2001629499 hasRelatedWork W2133339247 @default.
- W2001629499 hasRelatedWork W2149410839 @default.
- W2001629499 hasRelatedWork W2190649397 @default.
- W2001629499 hasRelatedWork W2412177436 @default.
- W2001629499 hasVolume "17" @default.
- W2001629499 isParatext "false" @default.
- W2001629499 isRetracted "false" @default.
- W2001629499 magId "2001629499" @default.
- W2001629499 workType "article" @default.